• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, December 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Reston ebolavirus spreads efficiently in pigs

Bioengineer by Bioengineer
December 21, 2020
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Finding reveals potential for spread to humans

IMAGE

Credit: NIAID

WHAT:

Reston ebolavirus (RESTV) should be considered a livestock pathogen with potential to affect other mammals, including people, according to National Institutes of Health scientists. The caution comes from a study published in Proceedings of the National Academy of Sciences in which the scientists found that experimental piglets infected with RESTV developed severe respiratory disease and shed the virus from the upper respiratory tract. RESTV can infect humans but is not known to cause disease. Now the scientists express concern that pigs could serve as an “interim or amplifying host for ebolaviruses.”

“The emergence of RESTV in pigs is a wake-up call as transmission into humans through direct contact with pigs or the food chain is a possibility,” they state in their study report. Scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) conducted the work at Rocky Mountain Laboratories in Hamilton, Montana.

Scientists first identified RESTV in 1989 in research monkeys shipped from the Philippines to Reston, Virginia. The virus also gained attention in 2008 when an outbreak swept through pigs in the Philippines. That outbreak led to the first association of pig-to-human RESTV transmission, prompting the World Health Organization to issue a global alert in February 2009. RESTV sequences also have been identified in pigs in China, and the scientists suggest officials monitor pigs for disease throughout the Philippines and Southeast Asia.

The NIAID scientists conducted their study to answer two key questions: could they cause disease in young pigs–mimicking natural infection with RESTV isolated from the 2008 swine outbreak–and if so, would those pigs shed virus through their respiratory tract? Their work confirmed that in fact the pigs developed severe pneumonia with virus shedding from the upper respiratory tract. They also determined that the age of the piglets at the time of infection–they used animals between three and seven weeks old–did not change the course of disease. Their work involved Yorkshire cross-bred pigs, which frequently are used in commercial pig production systems. RESTV has not been found in commercial pigs in the United States.

Continued studies in this project will examine whether co-infection with other swine viruses affects the ability of RESTV to cause severe disease in pigs and whether pigs have a broad role in hosting ebolaviruses.

###

ARTICLE:

E Haddock et al. Reston virus causes severe respiratory disease in young domestic pigs. PNAS
DOI: 10.1073/pnas.2015657118 (2020).

WHO:

Heinz Feldmann, M.D., Ph.D., chief of NIAID’s Laboratory of Virology, and Elaine Haddock, Ph.D., Laboratory of Virology, are available to comment.

CONTACT:

To schedule interviews, please contact
Ken Pekoc,
(301) 402-1663,
[email protected].

NIAID conducts and supports research–at NIH, throughout the United States, and worldwide–to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH):

NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.

NIH…Turning Discovery Into Health®

Media Contact
Ken Pekoc
[email protected]

Related Journal Article

http://dx.doi.org/10.1073/pnas.2015657118

Tags: Infectious/Emerging DiseasesMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Monocyte-Lymphocyte Ratio: A Biomarker for Diabetic Neuropathy

December 26, 2025

Adapted Tango vs. Walking: 16-Month Parkinson’s Results

December 26, 2025

Unraveling Disease Clusters: Insights from Multimorbidity Review

December 26, 2025

Mitochondrial Autophagy: Key to Anti-Aging

December 26, 2025
Please login to join discussion

POPULAR NEWS

  • Nurses’ Views on Online Learning: Effects on Performance

    Nurses’ Views on Online Learning: Effects on Performance

    70 shares
    Share 28 Tweet 18
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    71 shares
    Share 28 Tweet 18
  • Unraveling Levofloxacin’s Impact on Brain Function

    54 shares
    Share 22 Tweet 14
  • Exploring Audiology Accessibility in Johannesburg, South Africa

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Exploring Nonclassical Correlations in Bose-Einstein Condensates

Probiotics Boost Gut Health Post-Ovarian Cancer Surgery

Monocyte-Lymphocyte Ratio: A Biomarker for Diabetic Neuropathy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.